Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs
International Journal of Molecular Sciences · 01.10.2024 · 25 (19) · 10603
DOI: 10.3390/ijms251910603 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.10.2024. Verfasst von Teresa Alejo und 8 weiteren Autor:innen. Beteiligte Einrichtung: CerTest Biotec S.L., 50840 San Mateo de Gállego, Spain. Hauptthemen laut MEDLINE: Freeze Drying, Nanoparticles, RNA, Messenger, SARS-CoV-2. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gobierno de Aragón, Ministerio de Ciencia, Innovación y Universidades, Spanish Ministry of Science and Innovation/Spanish Research Agency.
Abstract (Originalsprache)
The success of mRNA vaccines against SARS-CoV-2 has prompted interest in mRNA-based pharmaceuticals due to their rapid production, adaptability, and safety. Despite these advantages, the inherent instability of mRNA and its rapid degradation in vivo underscores the need for an encapsulation system for the administration and delivery of RNA-based therapeutics. Lipid nanoparticles (LNPs) have proven the most robust and safest option for in vivo applications. However, the mid- to long-term storage of mRNA-LNPs still requires sub-zero temperatures along the entire chain of supply, highlighting the need to develop alternatives to improve mRNA vaccine stability under non-freezing conditions to facilitate logistics and distribution. Lyophilization presents itself as an effective alternative to prolong the shelf life of mRNA vaccines under refrigeration conditions, although a complex optimization of the process parameters is needed to maintain the integrity of the mRNA-LNPs. Recent studies have demonstrated the feasibility of freeze-drying LNPs, showing that lyophilized mRNA-LNPs retain activity and stability. However, long-term functional data remain limited. Herein, we focus on obtaining an optimized lyophilizable mRNA-LNP formulation through the careful selection of an optimal buffer and cryoprotectant and by tuning freeze-drying parameters. The results demonstrate that our optimized lyophilization process maintains LNP characteristics and functionality for over a year at refrigerated temperatures, offering a viable solution to the logistical hurdles of mRNA vaccine distribution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CerTest Biotec S.L., 50840 San Mateo de Gállego, Spain.
ORCID-Profile: Teresa Alejo, Alfonso Toro-Córdova, Diego de Miguel
Förderung
- Gobierno de Aragón
- Ministerio de Ciencia, Innovación y Universidades
- Spanish Ministry of Science and Innovation/Spanish Research Agency
- Torres Quevedo program
Zitieren
APA
Alejo, T., Toro-Córdova, A., Fernández, L., Rivero, A., Stoian, A. M., Pérez, L., Navarro, V., Martínez-Oliván, J., & de Miguel, D. (2024). Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs. International Journal of Molecular Sciences, 25(19), 10603. https://doi.org/10.3390/ijms251910603
Vancouver
Alejo T, Toro-Córdova A, Fernández L, Rivero A, Stoian AM, Pérez L, et al. Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs. International Journal of Molecular Sciences. 2024;25(19):10603. doi:10.3390/ijms251910603
BibTeX
@article{Alejo2024,
author = {Alejo, Teresa and Toro-Córdova, Alfonso and Fernández, Laura and Rivero, Andrea and Stoian, Andrei Mihai and Pérez, Luna and Navarro, Victor and Martínez-Oliván, Juan and de Miguel, Diego},
title = {Comprehensive Optimization of a Freeze-Drying Process Achieving Enhanced Long-Term Stability and In Vivo Performance of Lyophilized mRNA-LNPs},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {19},
pages = {10603},
doi = {10.3390/ijms251910603}
}
EUVIMED